Pharmafile Logo

Fleet Laboratories

Fleet Laboratories Ltd are part of the DDD Group of Companies which was established in 1912 and is still privately owned. We work with customers in the health and beauty industry manufacturing pharmaceutical products on behalf of the licence holder and developing and manufacturing toiletry products for both brand owners and retailers. We have a diverse range of customers, some of whom we have worked with for nearly 30 years. Depending on your business need, we have a flexible range of services available.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

94 Rickmansworth Road, Watford, Herts, WD18 7JJ, United Kingdom
+44 (0)1923 229251

 Latest Content from PMHub 

Showcasing our multichannel capabilities in Berlin

Join Anthill for conferences in October to understand how to bring value to HCPs through multichannel communications

DAM and CMS: managing assets to maximise adoption and value

Senior Account Executive Dave Wood talks us through what DAM and CMS are, the role they play in the future of healthcare marketing, and how they can be best utilised...

Lucid launch new recruitment campaign to attract top talent in medical writing

We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from...

Knowing your audience is key to successful medical education

Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both...

How to enable each healthcare professional to fully understand your product

Read these three articles to understand how working at an individual level benefits all customers:

Alzheimer’s disease: reviewing the immediate treatment horizon

Account Manager Stuart Goodman takes a look at some of the promising categories of Phase 3 treatments that could soon be available to patients with Alzheimer's disease.

A stumble, but not a fall – what’s next for Opdivo?

Blue Latitude Health's Louis Perdios talks about the daunting challenges faced by BMS after Opdivo's disappointing results.

Meet Anthill at conferences in London

October, the month of multichannel pharma marketing in London. Meet us at DigiPharm and Multichannel Excellence Summit

Immuno-oncology; bringing patients closer to treatment

What do the new immunotherapies in oncology mean for those stakeholders who need to understand and make decisions about treatment?